Company Filing History:
Years Active: 2021
Title: **Freddy Acosta: Innovator in Tablet Technology**
Introduction
Freddy Acosta, an inventive mind from Centerbrook, Connecticut, has made significant contributions to the pharmaceutical industry with his innovative work on tablets. With a strong focus on improving the durability of tablets, his unique approach has garnered him a patent that addresses a common issue faced by manufacturers and consumers alike.
Latest Patents
Acosta holds a patent for "Tablets with Improved Friability." This invention involves the preparation of tablets using friability reducing agents, which enhance the tablets' resistance to breakage and crumbling. The patent specifies that these agents include low molecular weight polyethylene glycol and other agents with at least three percent hydroxide moieties and a minimum of eighty percent water solubility at room temperature. His innovation not only ensures that the tablets maintain satisfactory hardness but also permits the use of various active agents and excipients, demonstrating versatility and practicality in tablet formulation.
Career Highlights
Currently, Acosta is associated with Tower Laboratories Ltd., where he continues to push the boundaries of pharmaceutical innovations. His work is instrumental in advancing tablet technology, making pharmaceuticals more reliable for consumers. With one patent to his name, Acosta reflects a commitment to enhancing product quality within the industry.
Collaborations
Freddy Acosta has had the opportunity to work alongside esteemed colleagues such as Allen H. Rau and Donald Stadolnik. Collaborating with such experienced professionals has likely enriched his work and broadened the impact of his innovations at Tower Laboratories Ltd.
Conclusion
Freddy Acosta’s innovative spirit and dedication to improving tablet technology highlight the vital role of inventors in the pharmaceutical landscape. With his patent on tablets with improved friability, Acosta is paving the way for more resilient and effective pharmaceutical products, ultimately benefiting both manufacturers and consumers alike.